Showing 1621-1630 of 2235 results for "".
- FDA Approves Once-Daily Oral Semaglutidehttps://modernaesthetics.com/news/fda-approves-once-daily-oral-semaglutide/2485258/The US Food and Drug Administration (FDA) has approved Novo Nordisk’s once-daily oral formulation of semaglutide, marketed as Wegovy® pill, marking the first oral GLP-1 receptor agonist approved for chronic weight management in the United States. The approval includes indications for adults with
- New Peptide Serum Complements In-Office Aesthetic Treatmentshttps://modernaesthetics.com/news/new-peptide-serum-complements-in-office-aesthetic-treatments/2485257/ZO® Skin Health has introduced the Peptide Facial Refining Concentrate, an advanced at-home serum formulated to complement professional aesthetic procedures and enhance overall facial rejuvenation. The launch adds to the company’s physician-dispensed portfolio with
- FDA: Most PFAS in Cosmetics Lack Adequate Safety Datahttps://modernaesthetics.com/news/fda-most-pfas-in-cosmetics-lack-adequate-safety-data/2485144/The U.S. Food and Drug Administration (FDA) announced that it has released its first congressionally mandated report under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), assessing the use and safety of perfluoroalkyl and polyfluoroalkyl substances (PF
- Rheologic Profiles Differ Markedly Between Cross-Linked and Non–Cross-Linked HA Fillers, Study Findshttps://modernaesthetics.com/news/rheologic-profiles-differ-markedly-between-cross-linked-and-noncross-linked-ha-fillers-study-finds/2485091/Non–cross-linked and cross-linked hyaluronic acid (HA) dermal fillers demonstrate distinct rheologic behaviors under mechanical stress, with potential implications for product selection and injection depth, according to a comparative analysis of commercially available fillers published online in
- New Simulation Study Suggests BoNT/A Restrictions May Be Overly Conservativehttps://modernaesthetics.com/news/new-simulation-study-suggests-bonta-restrictions-may-be-overly-conservative/2485067/A large-scale, simulation-based study challenges the long-standing 4-hour restriction on post-injection activity following botulinum neurotoxin A (BoNT/A) treatment, suggesting that everyday behaviors may have minimal impact on toxin spread. The study, published in Scientific Reports, em
- Senolytic Skincare Platform Backed by First Peer-Reviewed Studyhttps://modernaesthetics.com/news/senolytic-skincare-platform-backed-by-first-peer-reviewed-study/2485088/Robles BioCeutics, a regenerative dermatology company focused on senolytic and stem cell–inspired approaches, has published its first peer-reviewed article in The Journal of Translational Medicine, validating the scientific basis of its proprietary skin regeneration platform. The
- Dr. Charles Runels Explains Science Behind Popular PRP Procedures for Female Genitaliahttps://modernaesthetics.com/news/dr-charles-runels-explains-science-behind-popular-prp-procedures-for-female-genitalia/2485048/New clinical data presented by Charles Runels, MD, founder of the Cellular Medicine Association (CMA), reveal sustained improvements in female sexual function 1 year after treatment with the O-Shot®, a platelet-rich plasma (PRP) protocol for vaginal and clitoral injection. Dr. Runels share
- New Anatomical Model Enhances Understanding of Eyelid Dynamics in Blepharoplastyhttps://modernaesthetics.com/news/new-anatomical-model-enhances-understanding-of-eyelid-dynamics-in-blepharoplasty/2485032/A recent anatomic investigation offers new insight into the biomechanical dynamics of upper eyelid movement, with potential implications for optimizing blepharoplasty outcomes and improving complication management. The study, published in Aesthetic Plastic Surgery, combines clinical, cad
- FDA Clears Cutera truFlex® for Muscle Rehab, Recovery, and Post-Surgical Usehttps://modernaesthetics.com/news/fda-clears-cutera-truflex-for-muscle-rehab-recovery-and-post-surgical-use/2485023/Cutera, Inc. has announced that its truFlex® muscle stimulation system has received expanded US Food and Drug Administration (FDA) clearances for use in rehabilitation, recovery, and muscle wellness applications. Originally cleared for aesthetic body contouring, the system can now be used to stre
- New Study Supports Efficacy of Noninvasive Ultrasound for Cellulitehttps://modernaesthetics.com/news/new-study-supports-efficacy-of-noninvasive-ultrasound-for-cellulite/2485014/A novel ultrasound-based device featuring synchronous parallel beam technology with a high-density handpiece demonstrated significant improvement in the appearance of cellulite, according to findings from a new multicenter study published in Dermatologic Surgery. The open-label, n